neuroscience
Pfizer pumps $600m into venture fund, targeting neuroscience
June 7, 2018Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical
Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
Celgene bucks trend to strengthen neuroscience pipeline
March 21, 2018Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical
Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …
Shire announces split into two business units, downgrades revenue forecast
January 9, 2018Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
Amgen and Novartis partner on Alzheimer’s and migraine treatments
September 2, 2015Research and Development Alzheimer's disease, Amgen, Novartis, migraine, neurology, neuroscience
Amgen and Novartis have announced a global collaboration to develop neuroscience treatments in Alzheimer’s disease and migraine. The companies plan …
Working Life: Shire’s Mark Rus
November 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Working Life, mark rus, neuroscience
How did you find your way into your current role? After completing an MSc in Economics at the London School …
Pfizer partners with MedGenesis on Parkinson’s
September 16, 2014Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
AZ sets up Alzheimer’s research collaborative
July 13, 2012Research and Development Alzheimer's, AstraZeneca, neuroscience
AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …
AstraZeneca buys neuroscience molecules
July 13, 2012Research and Development Alzheimer's, AstraZeneca, neuroscience
AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …
Lilly invests in UK research base
May 2, 2012Research and Development Elil Lilly, Erl Wood, neuroscience
Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …
Lilly prepares late-stage pipeline boost
July 1, 2011Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology
Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …
Cerovive failure another blow for AstraZeneca
October 26, 2006Research and Development, Sales and Marketing AstraZeneca, Cerovive, neuroscience
A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
